Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient.

Xu, Yang; Ma, Renyan; Cai, Yun; Zheng, Xuqin

Xu, Yang; Ma, Renyan; Cai, Yun; Zheng, Xuqin.

Affiliation

Xu Y; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ma R; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Cai Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zheng X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Indian J Dermatol Venereol Leprol ; 84(6): 763, 2018.

Article in En | MEDLINE | ID: mdl-29363626

Subject(s)

Anti-Inflammatory Agents/administration & dosage; Graves Disease/therapy; Halcinonide/administration & dosage; Lasers, Gas/therapeutic use; Leg Dermatoses/therapy; Myxedema/therapy; Administration, Topical; Aged; Combined Modality Therapy; Graves Disease/complications; Graves Disease/diagnosis; Humans; Leg Dermatoses/complications; Leg Dermatoses/diagnosis; Male; Myxedema/complications; Myxedema/diagnosis; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Halcinonide / Graves Disease / Lasers, Gas / Leg Dermatoses / Anti-Inflammatory Agents / Myxedema Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: Indian J Dermatol Venereol Leprol Year: 2018 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google